Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Vinzón SE"'
Autor:
Vinzón SE; Laboratorio de Terapia Molecular y Celular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Lopez MV; Laboratorio de Terapia Molecular y Celular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Cafferata EGA; Laboratorio de Terapia Molecular y Celular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Soto AS; Laboratorio de Microbiología e Inmunología Molecular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Berguer PM; Laboratorio de Microbiología e Inmunología Molecular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Vazquez L; Unidad Operativa Centro de Contención Biológica, ANLIS Dr. Carlos G. Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Nusblat L; Unidad Operativa Centro de Contención Biológica, ANLIS Dr. Carlos G. Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Pontoriero AV; Servicio Virosis Respiratorias, Laboratorio Nacional de Referencia de Enfermedades Respiratorias Virales, Laboratorio Nacional de Referencia de SARS-CoV-2/COVID-19 OPS/OMS, INEI-ANLIS Dr Carlos G Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Belotti EM; Centro de Medicina Comparada, ICiVet-Litoral, Universidad Nacional del Litoral-CONICET; Esperanza, Santa Fe, 3080, Argentina., Salvetti NR; Centro de Medicina Comparada, ICiVet-Litoral, Universidad Nacional del Litoral-CONICET; Esperanza, Santa Fe, 3080, Argentina., Viale DL; Laboratorio de Terapia Molecular y Celular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Vilardo AE; Unidad Operativa Centro de Contención Biológica, ANLIS Dr. Carlos G. Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Avaro MM; Servicio Virosis Respiratorias, Laboratorio Nacional de Referencia de Enfermedades Respiratorias Virales, Laboratorio Nacional de Referencia de SARS-CoV-2/COVID-19 OPS/OMS, INEI-ANLIS Dr Carlos G Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Benedetti E; Servicio Virosis Respiratorias, Laboratorio Nacional de Referencia de Enfermedades Respiratorias Virales, Laboratorio Nacional de Referencia de SARS-CoV-2/COVID-19 OPS/OMS, INEI-ANLIS Dr Carlos G Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Russo ML; Servicio Virosis Respiratorias, Laboratorio Nacional de Referencia de Enfermedades Respiratorias Virales, Laboratorio Nacional de Referencia de SARS-CoV-2/COVID-19 OPS/OMS, INEI-ANLIS Dr Carlos G Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Dattero ME; Servicio Virosis Respiratorias, Laboratorio Nacional de Referencia de Enfermedades Respiratorias Virales, Laboratorio Nacional de Referencia de SARS-CoV-2/COVID-19 OPS/OMS, INEI-ANLIS Dr Carlos G Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Carobene M; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (UBA-CONICET), Ciudad Autónoma de Buenos Aires, C1121ABG, Buenos Aires, Argentina., Sánchez-Lamas M; Securitas Biosciences, Montevideo, 11100, Uruguay., Afonso J; Area de Bioterio, Fundación Instituto Leloir; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Heitrich M; Laboratorio de Terapia Molecular y Celular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina., Cristófalo AE; Centro de Re-diseño e Ingeniería de Proteínas (CRIP), Universidad Nacional de San Martín, San Martin, Buenos Aires, 1650, Argentina., Otero LH; Centro de Re-diseño e Ingeniería de Proteínas (CRIP), Universidad Nacional de San Martín, San Martin, Buenos Aires, 1650, Argentina.; Departamento de Biología Molecular, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Instituto de Biotecnología Ambiental y Salud, CONICET, Universidad Nacional de Río Cuarto, Córdoba, X5804BYA, Argentina., Baumeister EG; Servicio Virosis Respiratorias, Laboratorio Nacional de Referencia de Enfermedades Respiratorias Virales, Laboratorio Nacional de Referencia de SARS-CoV-2/COVID-19 OPS/OMS, INEI-ANLIS Dr Carlos G Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Ortega HH; Centro de Medicina Comparada, ICiVet-Litoral, Universidad Nacional del Litoral-CONICET; Esperanza, Santa Fe, 3080, Argentina., Edelstein A; Unidad Operativa Centro de Contención Biológica, ANLIS Dr. Carlos G. Malbrán; Ciudad Autónoma de Buenos Aires, C1282AFF, Buenos Aires, Argentina., Podhajcer OL; Laboratorio de Terapia Molecular y Celular, Fundación Instituto Leloir-CONICET; Ciudad Autónoma de Buenos Aires, C1405BWE, Buenos Aires, Argentina. opodhajcer@leloir.org.ar.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2023 Oct 04; Vol. 8 (1), pp. 149. Date of Electronic Publication: 2023 Oct 04.
Autor:
López MV; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Vinzón SE; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Cafferata EGA; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Núñez FJ; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Soto A; Laboratory of Immunology and Molecular Microbiology, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Sanchez-Lamas M; Securitas Biosciences, Montevideo 11100, Uruguay., Afonso MJ; Fundación Instituto Leloir, Buenos Aires C1405BWE, Argentina., Aguilar-Cortes D; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Ríos GD; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Maricato JT; Discipline of Microbiology, Department of Microbiology, Immunology and Parasitology-DMIP, Paulista School of Medicine, Federal University of São Paulo-UNIFESP, Sao Pablo 04021-001, Brazil., Braconi CT; Discipline of Microbiology, Department of Microbiology, Immunology and Parasitology-DMIP, Paulista School of Medicine, Federal University of São Paulo-UNIFESP, Sao Pablo 04021-001, Brazil., Silveira VB; Discipline of Microbiology, Department of Microbiology, Immunology and Parasitology-DMIP, Paulista School of Medicine, Federal University of São Paulo-UNIFESP, Sao Pablo 04021-001, Brazil., Andrad TM; Discipline of Microbiology, Department of Microbiology, Immunology and Parasitology-DMIP, Paulista School of Medicine, Federal University of São Paulo-UNIFESP, Sao Pablo 04021-001, Brazil., Bonetti TCS; Discipline of Gynecology, Department of Medicine, Paulista School of Medicine, Federal University of São Paulo-UNIFESP, Sao Pablo 04021-001, Brazil., Ramos Janini LM; Discipline of Microbiology, Department of Microbiology, Immunology and Parasitology-DMIP, Paulista School of Medicine, Federal University of São Paulo-UNIFESP, Sao Pablo 04021-001, Brazil., Girão MJBC; Discipline of Gynecology, Department of Medicine, Paulista School of Medicine, Federal University of São Paulo-UNIFESP, Sao Pablo 04021-001, Brazil., Llera AS; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Gomez KA; Laboratorio de Biología e Inmunología de las Infecciones por Tripanosomátidos, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular Dr. Héctor N. Torres (CONICET), Buenos Aires C1428ADN, Argentina., Ortega HH; Centro de Medicina Comparada (ICiVet-Litoral), Universidad Nacional del Litoral-CONICET, Santa Fe S3080HOF, Argentina., Berguer PM; Laboratory of Immunology and Molecular Microbiology, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina., Podhajcer OL; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir-CONICET (IIBBA), Buenos Aires C1405BWE, Argentina.
Publikováno v:
Vaccines [Vaccines (Basel)] 2021 Sep 29; Vol. 9 (10). Date of Electronic Publication: 2021 Sep 29.
Autor:
Fu Y; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Cao R; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Schäfer M; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Stephan S; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Braspenning-Wesch I; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Schmitt L; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Bischoff R; Division of Functional Genome Analysis, Research Program 'Functional and Structural Genomics', German Cancer Research Center, Heidelberg, Germany., Müller M; Research Group Tumorvirus-specific Vaccination Strategies, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Schäfer K; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Vinzón SE; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Rösl F; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Hasche D; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany.
Publikováno v:
ELife [Elife] 2020 Aug 04; Vol. 9. Date of Electronic Publication: 2020 Aug 04.
Autor:
Hasche D; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany., Vinzón SE; Laboratory of Molecular and Cellular Therapy, Fundación Instituto Leloir, IIBBA-CONICET, Buenos Aires, Argentina., Rösl F; Division of Viral Transformation Mechanisms, Research Program 'Infection, Inflammation and Cancer', German Cancer Research Center, Heidelberg, Germany.
Publikováno v:
Frontiers in microbiology [Front Microbiol] 2018 May 02; Vol. 9, pp. 874. Date of Electronic Publication: 2018 May 02 (Print Publication: 2018).
Autor:
Hasche D; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Stephan S; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Braspenning-Wesch I; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mikulec J; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Virus-associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany., Niebler M; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Gröne HJ; Division of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Flechtenmacher C; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Akgül B; Institute of Virology, University of Cologne, Cologne, Germany., Rösl F; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Vinzón SE; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2017 Nov 30; Vol. 13 (11), pp. e1006723. Date of Electronic Publication: 2017 Nov 30 (Print Publication: 2017).
Autor:
Hasche D; Division of Viral Transformation Mechanisms (F030), German Cancer Research Center, Heidelberg, Germany., Stephan S; Division of Viral Transformation Mechanisms (F030), German Cancer Research Center, Heidelberg, Germany., Savelyeva L; Division of Neuroblastoma Genomics (B087), German Cancer Research Center, Heidelberg, Germany., Westermann F; Division of Neuroblastoma Genomics (B087), German Cancer Research Center, Heidelberg, Germany., Rösl F; Division of Viral Transformation Mechanisms (F030), German Cancer Research Center, Heidelberg, Germany., Vinzón SE; Division of Viral Transformation Mechanisms (F030), German Cancer Research Center, Heidelberg, Germany.
Publikováno v:
PloS one [PLoS One] 2016 Aug 17; Vol. 11 (8), pp. e0161283. Date of Electronic Publication: 2016 Aug 17 (Print Publication: 2016).
Autor:
Salvermoser M; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Chotewutmontri S; Genomics and Proteomics Core Facilities, German Cancer Research Center (DKFZ), Heidelberg, Germany., Braspenning-Wesch I; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hasche D; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rösl F; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Vinzón SE; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
The Journal of general virology [J Gen Virol] 2016 Jul; Vol. 97 (7), pp. 1658-1669. Date of Electronic Publication: 2016 Apr 04.
Autor:
Darvin ME; Charité-Universitätsmedizin Berlin, Department of Dermatology, Venerology, and Allergology, Charitéplatz 1, 10117 Berlin, Germany., Thiede G; Charité-Universitätsmedizin Berlin, Department of Dermatology, Venerology, and Allergology, Charitéplatz 1, 10117 Berlin, Germany., Ascencio SM; Charité-Universitätsmedizin Berlin, Department of Dermatology, Venerology, and Allergology, Charitéplatz 1, 10117 Berlin, GermanybCentro de Investigación e Innovación Tecnológica (CIITEC) del Instituto Politécnico Nacional (IPN), Cerrada de Cecati S/N, Co., Schanzer S; Charité-Universitätsmedizin Berlin, Department of Dermatology, Venerology, and Allergology, Charitéplatz 1, 10117 Berlin, Germany., Richter H; Charité-Universitätsmedizin Berlin, Department of Dermatology, Venerology, and Allergology, Charitéplatz 1, 10117 Berlin, Germany., Vinzón SE; DKFZ-Division of Viral Transformation Mechanisms, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany., Hasche D; DKFZ-Division of Viral Transformation Mechanisms, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany., Rösl F; DKFZ-Division of Viral Transformation Mechanisms, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany., May R; Telormedix S.A, Via Lugano 13, Agno CH-6982, Switzerland., Hazot Y; Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann-Science Park, Rehovot 7670402, Israel., Tamarkin D; Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann-Science Park, Rehovot 7670402, Israel., Lademann J; Charité-Universitätsmedizin Berlin, Department of Dermatology, Venerology, and Allergology, Charitéplatz 1, 10117 Berlin, Germany.
Publikováno v:
Journal of biomedical optics [J Biomed Opt] 2016 May 31; Vol. 21 (5), pp. 55004.
Autor:
Vinzón SE; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Braspenning-Wesch I; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Müller M; Research Group Tumorvirus-specific Vaccination, German Cancer Research Center (DKFZ), Heidelberg, Germany., Geissler EK; Department of Surgery, Experimental Surgery Division, University of Regensburg, Regensburg, Germany., Nindl I; Department of Dermatology, Venereology and Allergy, Skin Cancer Center Charité, University Hospital of Berlin, Berlin, Germany., Gröne HJ; Department of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Schäfer K; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rösl F; Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2014 Feb 20; Vol. 10 (2), pp. e1003924. Date of Electronic Publication: 2014 Feb 20 (Print Publication: 2014).